Advanced search
Publication Cover
Modern Rheumatology Case Reports Volume 5, 2021 - Issue 2
Journal homepage
84
Views
1
CrossRef citations to date
0
Altmetric
Case Reports

Tofacitinib‐induced subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis

Hakan Apaydına Department of Rheumatology, Ankara City Hospital, Ankara, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7219-1457
ORCID Icon &
Şükran Ertenb Department of Rheumatology, Ankara Yıldırım Beyazıt University Medical Faculty, Ankara, Turkey
Pages 254-258 | Received 14 Oct 2020, Accepted 04 Jan 2021, Published online: 18 Feb 2021

References

  • Atwater BD, Ai Z, Wolff MR. Fulminant myopericarditis from phenytoin-induced systemic lupus erythematosus. WMJ. 2008;107:298–300.
  • Vedove CD, Simon JC, Girolomoni G. Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents . J Dtsch Dermatol Ges. 2012;10:889–897.
  • Williams EL, Gadola S, Edwards CJ. Anti-TNF-induced lupus. Rheumatology (Oxford). 2009;48:716–720.
  • Solhjoo M, Bansal P, Goyal A, et al. Drug-induced lupus erythematosus [ınternet]. Treasure Island (FL): Stat Pearls; 2020.
  • Stark GR, Darnell JE Jr. The JAK-STAT pathway at twenty. Immunity. 2012;36:503–514.
  • Hile GA, Gudjonsson JE, Kahlenberg JM. The influence of interferon on healthy and diseased skin. Cytokine. 2020;132:154605.
  • Borg FA, Isenberg DA. Syndromes and complications of interferon therapy. Curr Opin Rheumatol. 2007;19:61–66.
  • Williams VL, Cohen PR. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists . Int J Dermatol. 2011;50:619–625.
  • Schwartz DM, Kanno Y, Villarino A, et al. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov. 2017;16:843–862.
  • Epstein A, Barland P. The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus. Arthritis Rheum. 1985;28:158–162.
  • Vedove CD, Del Giglio M, Schena D, et al. Drug-induced lupus erythematosus. Arch Dermatol Res. 2009;301:99–105.
  • Al‐Niaimi F. Adalimumab‐induced lupus erythematosus. Eur J Dermatol. 2009;19:380.
  • Antonov D, Kazandjieva J, Etugov D, et al. Drug-induced lupus erythematosus. Clin Dermatol. 2004;22:157–166.
  • Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–245.
  • Marzano AV, Vezzoli P, Crosti C. Drug-induced lupus: an update on its dermatologic aspects. Lupus. 2009;18:935–940.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.